================================================================================
MAPLE POINT HEALTH - TRANSFER PRICING & INTERCOMPANY DOCUMENTATION PACKAGE
COMPLETE TRANSFER PRICING COMPLIANCE PACKAGE
================================================================================

PREPARED DATE: January 31, 2024
EFFECTIVE DATE: January 1, 2024
PREPARED BY: Transfer Pricing Consultant (External)
REVIEWED BY: Chief Financial Officer, General Counsel

================================================================================
EXECUTIVE SUMMARY
================================================================================

This comprehensive Transfer Pricing & Intercompany Documentation Package has been
prepared to ensure full compliance with IRS transfer pricing requirements and to 
support the Company during acquisition due diligence.

KEY COMPONENTS:

✓ Master Intercompany Services Agreement (MSA) - Executed with all clinic entities
✓ Transfer Pricing Policy Document - Detailed policy with benchmarking support
✓ Cost Allocation Manual - Step-by-step allocation methodology
✓ Benchmarking Analysis - Comparable company study supporting 6% mark-up
✓ Contemporaneous Documentation - Board minutes, memos, email chains, certifications
✓ Cost Allocation Schedules - Sample monthly calculations and annual true-up

TRANSFER PRICING METHODOLOGY:

Method:         Cost Plus (TNMM - Transactional Net Margin Method)
Mark-Up Rate:   6.0% (arm's length mark-up on centralized services)
Pricing:        Direct Costs + (6% × Direct Costs)
Effective:      January 1, 2024, ongoing

COMPLIANCE STATUS: FULL - All documentation prepared contemporaneously and IRS-ready

================================================================================
DOCUMENT INVENTORY
================================================================================

FILE #1: Master Intercompany Services Agreement (MSA)
─────────────────────────────────────────────────────────────────────────────
Filename:       01_Master_Intercompany_Services_Agreement_ANONYMIZED.docx
Pages:          ~15 pages
Status:         EXECUTED by all parties (signatures obtained January 2024)
Purpose:        Formal legal agreement documenting the provision of services
Scope:          Defines service categories, pricing methodology, cost allocation,
                payment terms, liability, confidentiality, termination provisions
Parties:        Maple Point Management Services Co. (Service Provider) and 
                62 Clinic Entities (Service Recipients)
Key Terms:      Services charged at cost + 6% mark-up; monthly invoicing;
                30-day payment terms; annual true-up reconciliation

FILE #2: Transfer Pricing Policy Document
─────────────────────────────────────────────────────────────────────────────
Filename:       02_Transfer_Pricing_Policy_Document_ANONYMIZED.docx
Pages:          ~25 pages
Status:         APPROVED by Transfer Pricing Committee (January 15, 2024)
Purpose:        Comprehensive transfer pricing policy documentation
Scope:          Business description, functional analysis (FAR), transfer
                pricing methodology rationale, benchmarking analysis, cost
                allocation methodology, regulatory compliance framework,
                risk assessment
Content:        
  • Section 1: Executive Summary
  • Section 2: Business Description (company overview, structure, service model)
  • Section 3: Functional Analysis (MPMSC functions/assets/risks, Clinic functions/assets/risks)
  • Section 4: Transfer Pricing Methodology (selection rationale, Cost Plus method,
    benchmarking support for 6% mark-up, cost allocation methodology)
  • Section 5: Contemporaneous Documentation (enumeration of supporting docs)
  • Section 6: Regulatory Compliance (IRC §482, Treasury Regs, OECD Guidelines)
  • Section 7: Risk Assessment (strengths, risk areas, mitigation strategies)
  • Section 8: Management Certification

FILE #3: Contemporaneous Documentation Package
─────────────────────────────────────────────────────────────────────────────
Filename:       03_Contemporaneous_Documentation_Package_ANONYMIZED.docx
Pages:          ~35 pages
Status:         COMPLETED and Certified (January 31, 2024)
Purpose:        Comprehensive documentation satisfying IRC §482 and Revenue
                Procedure 98-34 contemporaneous documentation requirements
Contents:
  
  Document 1: BOARD MEETING MINUTES (January 15, 2024)
  ────────────────────────────────────
  • Meeting of Transfer Pricing Committee
  • Attendees: [CEO], [CFO], [COO], [CMO], [General Counsel], [External Consultant]
  • Agenda items: Background on transfer pricing, benchmarking study review,
    cost allocation methodology discussion, Q&A and committee resolution
  • Resolutions passed: Approval of TP Policy, MSA, cost allocation methodology,
    management authorization for ongoing compliance
  • All action items documented with completion dates

  Document 2: TRANSFER PRICING STUDY ENGAGEMENT MEMORANDUM (December 1, 2023)
  ────────────────────────────────────
  • Engagement letter from Transfer Pricing Consultant to Maple Point Health
  • Scope of work: Benchmarking study, TP policy documentation, MSA review,
    compliance support
  • Project timeline and deliverables
  • Preliminary findings and professional standards
  • Engagement confirmation

  Document 3: EMAIL CHAIN - TRANSFER PRICING DISCUSSION & APPROVAL
  ────────────────────────────────────
  • Email #1 (11/15/23): Initial kickoff with consultant and legal counsel
  • Email #2 (12/20/23): Preliminary findings from benchmarking study
  • Email #3 (1/15/24): Post-board approval and action item confirmation
  • Email #4 (1/29/24): Final Transfer Pricing Study Report delivery
  • Evidence of contemporaneous communication and approval process

  Document 4: MANAGEMENT MEMORANDUM (January 10, 2024)
  ────────────────────────────────────
  • Memorandum from Chief Financial Officer to Transfer Pricing Committee
  • Background on transfer pricing requirements
  • Proposed transfer pricing methodology and rationale
  • Benchmarking analysis highlights
  • Implementation plan and compliance framework
  • Management recommendations for approval

FILE #4: Cost Allocation Schedules & Benchmarking Analysis
─────────────────────────────────────────────────────────────────────────────
Filename:       04_Cost_Allocation_Schedules.xlsx
Sheets:         4 detailed worksheets with calculations
Status:         TEMPLATES COMPLETED - Ready for monthly/annual use
Purpose:        Detailed cost allocation methodology and supporting schedules

SHEET 1: COST ALLOCATION MANUAL
  • Detailed narrative description of cost allocation methodology
  • For each cost category, defines:
    - Cost pool scope and what costs are included
    - Allocation driver (basis for distributing costs to clinics)
    - Calculation methodology and formulas
    - Data sources and timing
  • Coverage: RCM, Clinical Operations, IT, HR, Finance, Marketing, Occupancy, D&A

SHEET 2: SAMPLE COST ALLOCATION (February 2024)
  • Real example of how costs are allocated to individual clinics
  • Shows allocation for 7 sample clinics (IL, MI, IN, OH, PA, WI, MN)
  • Demonstrates actual calculation using drivers and totals
  • Includes 6% mark-up calculation
  • Shows invoice amount = Allocated Costs × 1.06

SHEET 3: BENCHMARKING SUMMARY
  • 17 comparable healthcare MSOs with mark-up rates
  • Statistical analysis: minimum, 25th percentile, median, mean, 75th percentile, maximum
  • Interquartile range (IQR) analysis
  • Selection justification for 6.0% mark-up (positioned at median, defensible)
  • Regulatory compliance framework reference

SHEET 4: ANNUAL TRUE-UP TEMPLATE
  • Template for year-end reconciliation (March 31 annual true-up)
  • Columns: Actual Costs, Invoiced Amount, Variance
  • Shows calculation of net adjustment required
  • Used to adjust for any overpayment or underpayment during the year
  • Ensures allocation accuracy and compliance

FILE #5: CFO Transfer Pricing Certification
─────────────────────────────────────────────────────────────────────────────
Filename:       05_CFO_Transfer_Pricing_Certification_ANONYMIZED.docx
Pages:          ~2-3 pages
Status:         SIGNED and DATED (January 31, 2024)
Purpose:        Formal certification of transfer pricing methodology
Contents:       
  • Certification that transfer pricing policy is arm's length
  • Certification of compliance with IRC §482 and Treasury Regulations
  • Certification of contemporaneous documentation maintenance
  • Certification that pricing has been applied consistently
  • Certification under penalty of perjury
  • Signature of Chief Financial Officer with certification date

================================================================================
TRANSFER PRICING OVERVIEW
================================================================================

INTERCOMPANY TRANSACTION TYPES:

1. CENTRALIZED SERVICES (Primary Transaction)
   ───────────────────────────────────────────
   Service Provider: Maple Point Management Services Co. (MPMSC)
   Recipients:      62 Clinic Entities across 7 states
   Services:        Revenue Cycle Management, Clinical Operations, IT, HR,
                    Finance & Admin, Marketing & Growth
   Pricing:         Cost + 6% Mark-Up
   Allocation:      Based on documented drivers (claims, patients, users, etc.)
   Frequency:       Monthly invoicing with annual true-up
   Documentation:   Cost accounting records, allocation schedules

2. INTELLECTUAL PROPERTY LICENSING (Ancillary)
   ──────────────────────────────────────────────
   Licensor:        MPMSC
   Licensees:       All Clinic Entities
   IP Licensed:     EHR templates, care coordination algorithms, clinical
                    protocols, brand assets
   Royalty:         Included in 6% mark-up (no separate royalty)
   Term:            Continuous during service agreement

3. INTERCOMPANY LOANS (Growth Support)
   ────────────────────────────────────
   Lender:          MPMSC
   Borrowers:       Clinic Entities opening new locations
   Interest Rate:   6.25% fixed (arm's length rate for healthcare loans)
   Term:            5 years or clinic IRR breakeven
   Documentation:   Promissory notes, payment records

================================================================================
COMPLIANCE FRAMEWORK
================================================================================

REGULATORY REQUIREMENTS SATISFIED:

✓ Internal Revenue Code (IRC) Section 482
  "In any case of two or more organizations, trades, or businesses...which are
   owned or controlled directly or indirectly by the same interests, the
   Secretary may distribute...the gross income, deductions...between or among
   such organizations..."
  COMPLIANCE: All intercompany pricing reflects arm's length terms

✓ Treasury Regulation Section 1.482-4 (Transfer Pricing Methods)
  "The arm's length result of a controlled transaction under the best method rule
   must be determined under the method that provides the most accurate
   determination of an arm's length result."
  COMPLIANCE: Cost Plus method selected as most appropriate; benchmarking supports

✓ Treasury Regulation Section 1.482-7 (Documentation Requirements)
  Contemporaneous documentation must include:
  - Controlled transactions identification
  - Functional analysis
  - Economic analysis
  - Transfer pricing method selection
  - Benchmarking study support
  COMPLIANCE: All elements documented

✓ Revenue Procedure 98-34 (Contemporaneous Documentation Safe Harbor)
  To qualify for safe harbor protection, documentation must be:
  - Prepared or obtained contemporaneously with tax return
  - Attached to or filed with tax return
  - Demonstrates arm's length nature of prices
  COMPLIANCE: Documentation prepared in January 2024 for FY 2024 tax return

✓ OECD Transfer Pricing Guidelines (2022 Edition)
  - Arm's length principle
  - Transfer pricing methods (CUP, Cost Plus, Resale Price, Profit Split, TNMM)
  - Documentation requirements
  - Economic substance analysis
  COMPLIANCE: All OECD principles applied to methodology selection

✓ State Tax Authority Requirements
  - Multi-state allocation and apportionment
  - Related party transaction disclosure
  - Reasonable compensation limits (if applicable)
  COMPLIANCE: Policy supports state tax compliance

================================================================================
KEY FINANCIAL METRICS & SUPPORTING DATA
================================================================================

2024 PROJECTED INTERCOMPANY TRANSACTION VOLUMES:

Service Fees (Cost + 6%):        $54,400,000 annually
  • RCM/Claims Processing:       $15,000,000 direct + $900,000 mark-up
  • Clinical Operations:         $10,200,000 direct + $612,000 mark-up
  • Information Technology:      $7,800,000 direct + $468,000 mark-up
  • Human Resources:             $5,400,000 direct + $324,000 mark-up
  • Finance & Administration:    $4,575,000 direct + $274,500 mark-up
  • Marketing & Growth:          $3,300,000 direct + $198,000 mark-up
  • Occupancy & Facilities:      $5,100,000 direct + $306,000 mark-up
  • Corporate Administration:    $2,625,000 direct + $157,500 mark-up

IP Licensing Royalty:            $0 (included in mark-up)

Intercompany Loan Interest:      ~$1,600,000 annually (at 6.25% on outstanding balances)

TOTAL INTERCOMPANY VOLUME:       ~$56,000,000 annually

================================================================================
DOCUMENTATION RETENTION & MAINTENANCE
================================================================================

RECORD RETENTION POLICY:

Documents Retained:              All transfer pricing documentation
Retention Period:                Minimum 7 years (per IRS exam statute of limitations)
Location:                        Corporate Headquarters, Finance Department
Backup Copies:                   Digital copies maintained in secure file server
Responsible Party:               Chief Financial Officer and Finance Department
Access:                          Available for IRS examination or company audits

ANNUAL UPDATES:

Frequency:                       Annually (by January 31 following fiscal year-end)
Process:                         
  • Review actual costs vs. invoiced amounts
  • Perform year-end true-up reconciliation
  • Update benchmarking analysis (or engage external consultant annually)
  • Document any changes in business model or service scope
  • Certify compliance by Chief Financial Officer
  • Present to Transfer Pricing Committee for review/approval

Changes to Policy:               Any material changes in service scope, business
                                model, or organizational structure must be reviewed
                                for transfer pricing implications and documented

================================================================================
IRS AUDIT DEFENSE STRATEGY
================================================================================

EXAMINATION SCENARIOS & RESPONSE:

Scenario 1: IRS Questions Whether 6% Mark-Up Is Arm's Length
Response:   • Provide benchmarking study showing 3.5%-8.2% range
            • Present comparable company database with peer group analysis
            • Explain selection of median (6.0%) as conservative position
            • Demonstrate that MPMSC functions align with comparables
            • Show cost accounting records support allocation methodology

Scenario 2: IRS Challenges Cost Allocation Methodology
Response:   • Provide detailed Cost Allocation Manual with allocation drivers
            • Submit contemporaneous documentation of cost pool definitions
            • Show sample monthly invoices demonstrating consistent application
            • Present allocation reconciliation to general ledger
            • Demonstrate allocation drivers are objective and documented

Scenario 3: IRS Requests Documentation of Arm's Length Negotiations
Response:   • Provide Board meeting minutes showing Transfer Pricing Committee
              review and approval
            • Submit email chain documenting decision process
            • Provide Management Memorandum explaining methodology rationale
            • Present engagement letter and study report
            • Provide certification of arm's length nature

Scenario 4: IRS Proposes Transfer Pricing Adjustment
Response:   • Challenge based on contemporaneous documentation support
            • Request competent authority review if applicable (Bilateral APAs)
            • Consider Advance Pricing Agreement (APA) to obtain IRS pre-clearance
              for future years
            • Engage transfer pricing counsel for amended returns if adjustment
              is upheld

ADVANCE PRICING AGREEMENT (APA) OPTION:

The Company may consider pursuing an IRS Advance Pricing Agreement (APA) to 
obtain pre-clearance of the transfer pricing methodology. This would provide
certainty and reduce audit risk. Documentation package prepared here would 
support an APA filing.

================================================================================
ACQUISITION DUE DILIGENCE CONSIDERATIONS
================================================================================

BUYER CONFIDENCE FACTORS:

This documentation package demonstrates to acquisition buyers that:

✓ Transfer Pricing is Defensible
  • Well-documented policy supported by benchmarking
  • Contemporaneous documentation contemporaneously prepared
  • Cost allocation methodology is objective and auditable
  • Reduces risk of IRS challenge post-acquisition

✓ Financial Statements Are Reliable
  • Intercompany pricing reflects arm's length terms
  • Transfer prices comply with IRC §482
  • No hidden liabilities from improper transfer pricing

✓ Management is Sophisticated
  • Demonstrates commitment to tax compliance
  • Shows understanding of regulatory requirements
  • Reduces acquirer's concerns about unknown tax liabilities

✓ Integration Risks Are Minimized
  • Centralized services model is proven and documented
  • Cost allocation methodology is transparent
  • Transfer pricing methodology supports post-acquisition integration

BUYER DUE DILIGENCE REQUESTS ADDRESSED:

Request 1: "Show us that intercompany pricing is arm's length"
Response: Provide Transfer Pricing Policy Document + Benchmarking Analysis

Request 2: "Are there any IRS transfer pricing issues?"
Response: Provide contemporaneous documentation showing full compliance

Request 3: "What is the cost of corporate overhead allocated to clinics?"
Response: Provide Cost Allocation Manual + Sample monthly invoices

Request 4: "How is this comparable to other healthcare providers?"
Response: Provide benchmarking study with comparable company data

Request 5: "Show me that this was properly approved and documented"
Response: Provide Board minutes + Email chain + Management memos + Certification

================================================================================
ENGAGEMENT SUMMARY - EXTERNAL CONSULTANT SERVICES
================================================================================

Consultant:                      Healthcare Transfer Pricing Specialist
Engagement Period:               November 2023 - January 2024
Project Scope:                   Transfer pricing study, benchmarking, policy
                                documentation, contemporaneous documentation
Key Deliverables:                ✓ Transfer Pricing Study Report
                                ✓ Benchmarking Analysis
                                ✓ Transfer Pricing Policy Document review
                                ✓ Cost Allocation Manual
                                ✓ Board presentation
                                ✓ Contemporaneous documentation support

Professional Standards:          • IRS Publication 556
                                • Treasury Regulation Section 1.482-7
                                • Revenue Procedure 98-34
                                • OECD Transfer Pricing Guidelines
                                • IRS APA Program standards

Certifications:                  All work performed by credentialed transfer
                                pricing professionals with healthcare industry
                                experience

================================================================================
NEXT STEPS & ONGOING COMPLIANCE
================================================================================

IMMEDIATE ACTIONS (Completed):

✓ Transfer Pricing Policy approved by Transfer Pricing Committee (1/15/24)
✓ Master Intercompany Services Agreement executed (1/30/24)
✓ Cost allocation system implemented and invoicing commenced (2/5/24)
✓ Chief Financial Officer Certification signed (1/31/24)
✓ Documentation package filed and retained (1/31/24)

QUARTERLY ACTIVITIES (Going Forward):

• Q1: Year-end true-up reconciliation and adjustment invoicing
• Q2: Review actual costs vs. budgeted costs; document any material changes
• Q3: Mid-year benchmarking update; confirm allocation methodology appropriateness
• Q4: Prepare for next year's documentation and policy review

ANNUAL ACTIVITIES (Calendar Year-End):

• Comprehensive year-end reconciliation and true-up
• Update benchmarking study (conduct annually or every 2-3 years with external consultant)
• Review changes in business model or service scope
• Document any changes to allocation methodology
• Transfer Pricing Committee review and approval
• Chief Financial Officer Certification and sign-off
• Tax return filing with contemporaneous documentation attachment

ONGOING MONITORING:

• Maintain detailed cost accounting records
• Track cost allocation drivers monthly (claims, patients, users, headcount, etc.)
• Monitor changes in comparable company landscape
• Monitor regulatory guidance and IRS positions on transfer pricing
• Maintain relationship with transfer pricing consultant for questions/guidance

================================================================================
DOCUMENT CHECKLIST FOR IRS EXAMINATION
================================================================================

If the IRS requests transfer pricing documentation, the following items should
be provided in this order:

□ Master Intercompany Services Agreement
□ Transfer Pricing Policy Document
□ Cost Allocation Manual
□ Benchmarking Study Report
□ Board Meeting Minutes (Transfer Pricing Committee)
□ Transfer Pricing Study Engagement Memorandum
□ Management Memorandum - Methodology Rationale
□ Sample Monthly Cost Allocation Invoices
□ General Ledger Support for Cost Pools
□ Cost Allocation Reconciliation (Actual to Invoiced)
□ Annual True-Up Reconciliation
□ Chief Financial Officer Certification Letter
□ Email chains demonstrating approval process
□ Tax Return Contemporaneous Documentation Attachment
□ Any amendments or updates to the policy

================================================================================
SUMMARY
================================================================================

This comprehensive Transfer Pricing & Intercompany Documentation Package provides
Maple Point Health Holdings, Inc. with:

✓ COMPLIANCE: Full documentation of arm's length transfer pricing satisfying
  IRS requirements under IRC §482, Treasury Regulations, and Rev. Proc. 98-34

✓ DEFENSIBILITY: Benchmarking support, functional analysis, and contemporaneous
  documentation prepared to defend against IRS challenges

✓ ACQUISITION READINESS: Documentation package demonstrates tax compliance to
  acquisition buyers and reduces post-acquisition transfer pricing risk

✓ OPERATIONAL CLARITY: Clear cost allocation methodology, monthly invoicing
  process, and annual reconciliation process

✓ ONGOING COMPLIANCE: Framework for annual updates, policy monitoring, and
  regulatory compliance going forward

The Company is now positioned to:
• File tax returns with confidence in transfer pricing methodology
• Defend methodology in IRS examination
• Support acquisition due diligence
• Maintain compliance in ongoing operations

================================================================================
END OF DOCUMENT
================================================================================
